Feasibility of proton chemical shift imaging with a stereotactic headframe.

Magn Reson Imaging

Department of Biomedical Engineering, Kangnam St Mary's Hospital, College of Medicine, the Catholic University of Korea, #505 Banpo-Dong, Seocho-Ku, 137-040, Seoul, South Korea.

Published: January 2003

To prove feasibility of proton chemical shift imaging ((1)H CSI) during stereotactic procedure, authors performed (1)H CSI in combination with a stereotactic headframe and selected targets according to local metabolic information, evaluated the pathologic results. The (1)H CSI directed stereotactic biopsy was performed in four patients. (1)H CSI and conventional Gd-enhancement stereotactic MRI were performed simultaneously after the fitting of a stereotactic headframe. Focal areas of increased phosphocholine(Cho)/phosphocreatine(Cr) and Lactate/Cr ratios were selected as target sites in the stereotactic MR images. (1)H CSI is possible with the stereotactic headframe in place. Pathologic samples taken from areas of increased Cho/Cr ratios and decreased NAA/Cr ratios provided information upon increased cellularity, mitoses and cellular atypism, and facilitated diagnosis. Pathologic samples taken from areas of increased Lac/Cr ratio showed predominant feature of necrosis. (1)H CSI was feasible with the stereotactic headframe in place. The final pathologic results obtained were concordant with the local metabolic information from (1)H CSI. We believe that (1)H CSI-directed stereotactic biopsy has the potential to significantly improve the accuracy of stereotactic biopsy targeting.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0730-725x(02)00628-8DOI Listing

Publication Analysis

Top Keywords

stereotactic headframe
20
stereotactic biopsy
12
areas increased
12
stereotactic
11
feasibility proton
8
proton chemical
8
chemical shift
8
shift imaging
8
csi stereotactic
8
local metabolic
8

Similar Publications

Stereotactic biopsy of posterior fossa lesions, which are often inoperable, enables a safe trajectory and provides tissue samples for accurate diagnosis, which is crucial for correct treatment since the latest World Health Organization Classification of Tumors of the Central Nervous System from 2021 places immense emphasis on molecular diagnostics. Stereotactic biopsy using the Leksell Vantage headframe is, due to its rigid design, extremely accurate, but stiffer, making the procedure more challenging and the learning curve steeper. This retrospective analysis demonstrates the introduction of the new Leksell Vantage headframe in day-to-day practice at the University Medical Center in Maribor, Slovenia, in demanding procedures of posterior fossa biopsies, and also provides a review of the literature available on the topic with emphasis on the technical aspect of posterior fossa biopsy using the Leksell Vantage headframe in adults.

View Article and Find Full Text PDF
Article Synopsis
  • The research aimed to compare two existing stereotactic brain biopsy (SBB) methods (3D-SCG and neuronavigation with Brainsight) against a new method using Brainsight with a 3D-printed headframe (BS3D-HF) for canine cadavers.
  • The study involved five canine cadavers, with initial CT scans taken, followed by the placement of pins at selected target points using each method, and then a repeat CT to assess accuracy.
  • Results showed that both 3D-SCG and neuronavigation had comparable median deviations (2.48 mm and 3.28 mm), while the BS3D-HF had a much larger median deviation (14.8 mm), indicating
View Article and Find Full Text PDF

Targeting Accuracy of the Leksell Vantage Stereotactic System for Deep Brain Stimulation Surgery: A Retrospective Review.

Oper Neurosurg (Hagerstown)

June 2023

Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Background: Compared with the Leksell G frame, the new Leksell Vantage stereotactic headframe offers many benefits during deep brain stimulation (DBS) procedures.

Objective: To define the "real-world" targeting accuracy of the Vantage frame for performing DBS lead implants.

Methods: Retrospective review of all patients who underwent DBS using the Vantage frame with our surgeon between July 2021 and May 2022.

View Article and Find Full Text PDF

Objectives: Accelerator-based stereotactic radiosurgery (SRS) is a noninvasive and effective treatment modality widely used for benign brain tumors. This study aims to report 20-year treatment outcomes in our institute.

Materials And Methods: From May 2001 to December 2020, 127 patients treated with LINAC-based single-fraction SRS for their benign brain lesions were included.

View Article and Find Full Text PDF

Frame-based stereotactic localization is an important step for targeting during a surgical procedure. The motion may cause artifacts in this step reducing the accuracy of surgical targeting. While modeling of motion in real-life scenarios may be difficult, herein we analyzed the case where motion was suspected to impact the localization step.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!